In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium

Antimicrob Agents Chemother. 2015 Dec;59(12):7818-22. doi: 10.1128/AAC.01733-15. Epub 2015 Sep 14.

Abstract

In vitro susceptibilities of a worldwide collection of molecularly identified Phaeoacremonium strains (n = 43) belonging to seven species and originating from human and environmental sources were determined for eight antifungal drugs. Voriconazole had the lowest geometric mean MIC (0.35 μg/ml), followed by posaconazole (0.37 μg/ml), amphotericin B (0.4 μg/ml), and isavuconazole (1.16 μg/ml). Caspofungin, anidulafungin, fluconazole, and itraconazole had no activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology*
  • Anidulafungin
  • Antifungal Agents / pharmacology*
  • Ascomycota / drug effects*
  • Ascomycota / growth & development
  • Ascomycota / isolation & purification
  • Caspofungin
  • Echinocandins / pharmacology
  • Fluconazole / pharmacology
  • Humans
  • Itraconazole / pharmacology
  • Lipopeptides / pharmacology
  • Microbial Sensitivity Tests
  • Mycoses / microbiology
  • Nitriles / pharmacology*
  • Pyridines / pharmacology*
  • Triazoles / pharmacology*
  • Voriconazole / pharmacology*

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Nitriles
  • Pyridines
  • Triazoles
  • Itraconazole
  • isavuconazole
  • posaconazole
  • Amphotericin B
  • Fluconazole
  • Anidulafungin
  • Caspofungin
  • Voriconazole